Information Provided By: 
Fly News Breaks for June 27, 2018
CSII
Jun 27, 2018 | 08:27 EDT
As previously reported, BofA/Merrill upgraded Cardiovascular Systems to Buy from Underperform and raised its price target to $40 from $30. Analyst Bob Hopkins believes the July 31 analyst day could be a catalyst for shares and reinforce a more sustainable growth outlook. Hopkins believes consistent 10%+ revenue growth is realistic based on both geographic expansion and new product introductions, and expects and expects double digit revenue growth guidance for next fiscal year.
News For CSII From the Last 2 Days
There are no results for your query CSII
